HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J results

This article was originally published in The Rose Sheet

Executive Summary

Adult skin and hair care business grew 14% in the third quarter, including approximately 1% positive currency impact, Johnson & Johnson says during Oct. 18 earnings call. In the U.S., "solid performances from our Neutrogena and RoC brands complemented by very strong results with Aveeno were major drivers of growth," firm notes, adding growth drivers outside the U.S. wereJohnson's adult products, Neutrogena and Clean & Clear anti-acne brand. Baby and kids' care sales grew 7%. Johnson's Bathtime Buddies led 3% revenue growth in the U.S., and Softlotion products and Bathtime Buddies drove 8% growth outside the U.S. Worldwide consumer product sales were $2.23 bil., up 10.2% including a positive currency impact of 1.7%, and U.S. sales in the segment increased 5.1% to $1.08 bil...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013448

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel